IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.40498
PubMed Identifier: 29609200
Publication URI: http://europepmc.org/abstract/MED/29609200
Type: Journal Article/Review
Volume: 70
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
Issue: 8
ISSN: 2326-5191